Paid Clinical Trials in Glendale, CA
As of August 2026, 97 paid clinical trials are recruiting in Glendale, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Glendale offers studies at sites including Los Angeles Cancer Network for conditions such as Healthy Participants, Breast Cancer, Major Depressive Disorder, Major Depressive Disorder (MDD). Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Glendale
Trials by drug in Glendale
Filter results
Newly added in Glendale
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
90 clinical trials
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract
Top Research Study Locations in Glendale
Researchers run research studies in Glendale, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Los Angeles Cancer Network | Colorectal Neoplasms, Anemia, B-Cell Non-Hodgkins Lymphoma | 9 |
| Global Research Management, Inc. | Macular Edema Secondary to Inflammation, Age-Related Macular Degeneration, Choroidal Neovascularization | 6 |
| Behavioral Research Specialists, LLC | Major Depressive Disorder (MDD), Alzheimer Disease, Depression | 6 |
| Adventist Health Glendale | Coronary Artery Disease, High-Risk Percutaneous Coronary Intervention, Hypertension | 5 |
| Global Research Management | Age Related Cataracts, Diabetic Macular Edema, Diabetic Retinopathy | 4 |
| California Clinical Trials Medical Group | Fentanyl Overdose, Fentanyl Poisoning, Methamphetamine Abuse | 3 |
| Kidney Disease Medical Group | End Stage Kidney Disease, Focal Segmental Glomerulosclerosis, Proteinuric Kidney Diseases | 3 |
| Los Angeles Hematology Oncology Medical Group | Breast Cancer, Breast Neoplasms, Colorectal Neoplasms | 2 |
| Clinical Trial Site | Advanced Breast Cancer, Breast Cancer, ER Positive Breast Cancer | 2 |
| Glendale Adventist Medical Center | Acute Ischemic Stroke, Carcinoma, Non-Small-Cell Lung | 2 |
| Neurocrine Clinical Site | Major Depressive Disorder | 2 |
| OPN Healthcare, Inc. | Non-small Cell Lung Cancer | 2 |
| PAREXEL Glendale/LA EPCU | Healthy Volunteers, Hyperuricemia, Obesity | 2 |
| Seaport Investigator Site | Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress | 2 |
| Los Angeles Cancer Network (LACN) | Metastatic Castration-Resistant Prostate Cancer | 1 |
| Adventist Medical Glendale | Lumbar Spinal Stenosis | 1 |
| Autobahn | Major Depressive Disorder | 1 |
| Avalon Surgery and Robotic Center | Lumbar Spinal Stenosis | 1 |
| Behavioral Research Specialists LLC | Depressive Disorder, Major | 1 |
| California Clinical Trials Medical Group - Parexel | Schizophrenia | 1 |
| Children's Hospital of Los Angeles | Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Autoimmune Diseases | 1 |
| City of Hope at Glendale | Metastatic Pancreatic Adenocarcinoma | 1 |
| Glendale Adventist | Coronary Artery Disease, Ischemic Heart Disease | 1 |
| Glendale Adventist Medical Center d/b/a Adventist Health Glendale | Acute Stroke, Ischemic Stroke, Stroke | 1 |
| Glendale, CA | Branch Retinal Vein Occlusion (BRVO), Neovascular Age-Related Macular Degeneration (NVAMD) | 1 |
Active & Upcoming Studies in Glendale (2026)
Recruiting trials in Glendale grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (25 active studies)
- A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. · Phase 2, Phase 3 · Eikon Therapeutics
- A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation · Phase 3 · Astellas Pharma Global Development, Inc.
Eye & vision (10 active studies)
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
- An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease · Phase 2 · Dompé Farmaceutici S.p.A
Cardiovascular (6 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities · Phase 3 · Weill Medical College of Cornell University
Mental health & behavior (5 active studies)
- A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder · Phase 3 · Cybin IRL Limited
Neurology & pain (4 active studies)
- Open-Label Extension Protocol to SNK01-AD01 Study · Phase 2 · NKGen Biotech, Inc.
- Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial · Phase 3 · Mercy Health Ohio
Diabetes & metabolic (3 active studies)
- Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity · Phase 1 · Regeneron Pharmaceuticals
- A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity · Phase 1 · Novo Nordisk A/S
Common conditions studied in Glendale
- Healthy Participants (6 active studies)
- Breast Cancer (5 active studies)
- Major Depressive Disorder (5 active studies)
- Major Depressive Disorder (MDD) (4 active studies)
- Non-small Cell Lung Cancer (4 active studies)
- Colorectal Neoplasms (3 active studies)
Leading research sponsors in Glendale
- AstraZeneca
- Boehringer Ingelheim
- Hoffmann-La Roche
- Janssen Research & Development, LLC
- Pfizer
Frequently asked questions
How many paid clinical trials are currently recruiting in Glendale?
There are approximately 97 recruiting clinical trials in Glendale, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Glendale pay participants?
Most recruiting trials in Glendale compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Glendale?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Glendale?
The most common conditions under active study in Glendale include Healthy Participants (6), Breast Cancer (5), Major Depressive Disorder (5), Major Depressive Disorder (MDD) (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Glendale?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Glendale on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Glendale?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Glendale?
Recruiting research sites in Glendale include Los Angeles Cancer Network, Global Research Management, Inc., Behavioral Research Specialists, LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Glendale right now?
The largest active categories in Glendale are Cancer & tumors (25), Eye & vision (10), Cardiovascular (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.